Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ranbaxy launches generic Lipitor in 4 EU markets
Reuters
Tuesday, March 6, 2012 - 9:22am
tags:
Ranbaxy, Europe, generics, Lipitor, Pfizer, Germany, Italy, Sweden, Netherlands
Approved Drug + Approved Drug = Rejection?
Motley Fool
Tuesday, March 6, 2012 - 9:21am
tags:
drug approvals, Merck, FDA, Zetia, Pfizer, Lipitor, MK-0653C
Biogen And Samsung Advance Biosimilars Venture
Seeking Alpha
Monday, March 5, 2012 - 6:18pm
tags:
biosimilars, Samsung, Biogen Idec
[video]U.S. Birth Control Market Growing
Bloomberg
Monday, March 5, 2012 - 6:17pm
tags:
birth control
AEterna, Keryx soar on study speculation
Marketwatch
Monday, March 5, 2012 - 6:16pm
tags:
Keryx, Aeterna Zentaris, perifosine, colorectal cancer, Multiple Myeloma
Most Popular Drug Manufacturers among Hedge Funds
Motley Fool
Monday, March 5, 2012 - 6:15pm
tags:
Pfizer, hedge funds, Sanofi, JNJ, Merck, Abbott Laboratories, Eli Lilly, Bristol-Myers Squibb
10 Biotechs Targeting Cancer Stem Cell Destruction
Minyanville
Monday, March 5, 2012 - 11:51am
tags:
stem cells, Stemica, OncoMed, KaloBios, Stemline, Formula Pharmaceuticals, Eclipse Pharmaceuticals, Verastem, ImmunoCellular, Geron, EntreMed
Immunocellular Thereapeutics: Pending Catalysts Could Spark Share Price Run
Seeking Alpha
Monday, March 5, 2012 - 11:48am
tags:
ImmunoCellular, Celgene, Dendreon, Oncothyreon, Teva Pharmaceuticals
Where The Jobs Are: A Hiring Index Actually Rose
Pharmalot
Monday, March 5, 2012 - 11:42am
tags:
jobs, pharma industry
Glaxo to Hire Hundreds in China as Reforms Widen Drug Access
Bloomberg
Monday, March 5, 2012 - 11:41am
tags:
China, drug reps, GSK
In Spite Of Dendreon's Woes, Other Players In The Sector Are Starting To Roll
Seeking Alpha
Monday, March 5, 2012 - 11:13am
tags:
Dendreon, Provenge, prostate cancer, Celldex, Agenus, Cel-Sci, ImmunoCellular
Exelixis announces initiation of trial combining cabozantinib, abiraterone
Yahoo/Fly on the Wall
Monday, March 5, 2012 - 11:12am
tags:
Exelixis, cabozantinib, abiraterone, prostate cancer
Seattle Genetics: A Cancer Niche Too Small
TheStreet.com
Monday, March 5, 2012 - 11:11am
tags:
Seattle Genetics, Adcetris, systemic anaplastic large cell lymphoma, Hodgkin's lymphoma
Threshold Scores Big With Pancreatic Cancer Data
Seeking Alpha
Monday, March 5, 2012 - 11:08am
tags:
pancreatic cancer, Threshold Pharmaceuticals, TH-302, Amgen, Array Biopharma, Micromet, Merck, Pharmacyclics
Lundbeck Anti-Binge Drinking Drug Helps Cut Intake 66% in Clinical Trials
Bloomberg
Monday, March 5, 2012 - 11:07am
tags:
Lundbeck, binge drinking, nalmefene
The Secret Reason Eli Lilly's Earnings Are Awesome
Motley Fool
Monday, March 5, 2012 - 11:06am
tags:
Eli Lilly, earnings
Merck: FDA won't OK its combo cholesterol drug now
Yahoo/AP
Monday, March 5, 2012 - 11:05am
tags:
FDA, Merck, Pfizer, Zetia
Abbott Laboratories' Share Price: Slightly Overvalued
Seeking Alpha
Monday, March 5, 2012 - 11:04am
tags:
Abbott Laboratories
Daiichi Sankyo, GlaxoSmithKline Form Vaccine Venture
WSJ Online
Monday, March 5, 2012 - 11:03am
tags:
GSK, vaccines, Daiichi Sankyo, Japan
Zogenix: Smart Biotech Buy Before Earnings
Seeking Alpha
Monday, March 5, 2012 - 11:02am
tags:
earnings, migraines, Zogenix, Sumavel DosePro, DosePro, Relday, Zohydro

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.